Press Release

CluePoints SVP of Business Development to Speak at Clinical Trials Europe

John Hall, SVP Business Development at CluePoints will share insights into the dimensions of risk associated with Decentralized Clinical Trials (DCTs) at Clinical Trials Europe.

The Dimensions of Risk Associated with DCT’s is a Spotlight Session on day 2 of the virtual summit.

From 1.35 pm on 3 November, John will share his expertise on the evolving landscape of DCTs.

He will discuss new dimensions of risk in decentralized research and how Centralized Monitoring technologies can provide effective oversight of key risks and ensure quality for new types of digital data.

John will also give insight into opportunities to maximize patient engagement and stakeholder interactions in decentralized trials.

John Hall

John is a senior life sciences executive with more than 15 years of experience commercializing high-value software, data analytics, and digital health technologies to the pharmaceutical and research industries.

John is currently SVP, Business Development at CluePoints and leads CluePoints commercial strategy and client relationships across Europe and the Asia Pacific.

He is also a subject matter expert in decentralized trials, digital biomarkers, and digital health solutions.

Prior to joining CluePoints, John was Head of Life Sciences at Huma, a digital health and decentralized trial tech provider, and held various commercial, product, and corporate development leadership roles at IXICO, an AIM-listed neuroscience imaging, and digital biomarker company.

He spent his early career in research, studying for a Ph.D. in Proteomics and Transcriptomics at the University of Durham for which he was sponsored by Amersham Biosciences (now GE Healthcare).

Clinical Trials Europe

Clinical Trials Europe is a leading event dedicated to streamlining clinical trials and improving patient outcomes.

The virtual conference takes place from 2-4 November and is delivered in the GMT time zone.

It is an opportunity to stay ahead with pioneering insights on COVID-19, decentralized clinical trials, patient recruitment and engagement strategies, real-world evidence, the Clinical Trials Regulation, and digital health.

Visit to book your pass and view the full agenda.

Press Release
CluePoints, a Leading Provider of AI-Driven Software Solutions for Clinical Data Review, Receives Significant Investment for Continued Growth from EQT
Press Release
CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’
Press Release
FDA And CluePoints Sign New 3 Year Cooperative Research And Development Agreement To Assess Data Quality Using Statistical Modelling And Machine Learning